AstraZeneca and Bristol Myers Squibb in Talks for Possible Merger, Creating Pharmaceutical Giant

British pharmaceutical giant AstraZeneca is said to be in talks with US rival Bristol Myers Squibb (BMS) for a possible merger.The Financial Times reported that if the deal goes through, it would create one of the world's largest pharmaceutical companies with an estimated combined value of nearly $400 billion.The companies have been discussing this potential tie-up over the past few months.